Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Blood Coagulation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03528551
What this trial is testing

A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 160
Not applicableStudy completedNCT00701545
What this trial is testing

A Canadian Study to Assess the Safety of Humate-P® Ivr (Infusion Volume Reduced)

Who this might be right for
Von Willebrand Disease
CSL Behring 21
Testing effectiveness (Phase 2)WithdrawnNCT00251277
What this trial is testing

Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura

Who this might be right for
Thrombotic Thrombocytopenic Purpura
Weill Medical College of Cornell University
Testing effectiveness (Phase 2)Study completedNCT01563458
What this trial is testing

Safety and Efficacy of Activated Recombinant Human Factor VII in Patients Undergoing Orthotopic Liver Transplantation

Who this might be right for
Acquired Bleeding DisorderBleeding During/Following Surgery
Novo Nordisk A/S 208
Not applicableActive Not RecruitingNCT06755658
What this trial is testing

RDW, Platelet Kinetics and Survival Outcome in Covid-19 Hospitalized Patients.

Who this might be right for
Infection by SARS-COV-2
Sismanoglio General Hospital 500
Large-scale testing (Phase 3)Study completedNCT00606060
What this trial is testing

BAY14-2222 Continuous Infusion in Surgeries

Who this might be right for
Hemophilia
Bayer 15
Not applicableEnrolling By InvitationNCT07163260
What this trial is testing

Defeat Rare Disease in Asia and Pacific (APAC) DRDA - Haemophilia

Who this might be right for
Haemophilia
Novo Nordisk A/S 244
Not applicableUnknownNCT05998733
What this trial is testing

The Impact of Coagulation Disorders on the Diagnosis and Prognosis of Sepsis

Who this might be right for
SepsisCoagulation Disorder
Ruijin Hospital 552
Testing effectiveness (Phase 2)Study completedNCT02273960
What this trial is testing

Study to Evaluate Safety and Efficacy in Adult Subjects With ITP

Who this might be right for
Immune Thrombocytopenic Purpura
Bristol-Myers Squibb 46
Not applicableStudy completedNCT00676858
What this trial is testing

Gas Embolism With Use of Argon Plasma Coagulation

Who this might be right for
Embolism, Air
Beth Israel Deaconess Medical Center 42
Not applicableUnknownNCT02324517
What this trial is testing

Ex Vivo Laboratory Assays Application for Therapy Tailoring in Patients With Severe Bleeding Disorders

Who this might be right for
Severe Hemophilia
Sheba Medical Center 300
Not applicableUnknownNCT01403740
What this trial is testing

Turkish Acquired Haemophilia Registry

Who this might be right for
Acquired Haemophilia
Turkish Society of Hematology 250
Not applicableEnded earlyNCT06257290
What this trial is testing

The Role of Platelet TLRs in Platelet Activation During VTE

Who this might be right for
Venous Thromboembolism
Centre Hospitalier Universitaire de Saint Etienne 44
Not applicableUnknownNCT03946384
What this trial is testing

Mutation p.Ile112Thr : Discrepancy Between Factor IX Level and Bleeding Phenotype

Who this might be right for
Hemophilia B
Centre Hospitalier Universitaire Dijon 12
Testing effectiveness (Phase 2)Ended earlyNCT04046848
What this trial is testing

Safety and Pharmacokinetics of Subcutaneous Injection of OCTA101 in Adult Patients With Severe Hemophilia A

Who this might be right for
Severe Hemophilia A
Octapharma 36
Testing effectiveness (Phase 2)Study completedNCT01568333
What this trial is testing

A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Shandong University 45
Not applicableEnded earlyNCT00299949
What this trial is testing

Thrombin Generation and Thromboelastography in Non-overt DIC

Who this might be right for
SepsisDisseminated Intravascular Coagulation
The University of Texas Health Science Center, Houston 2
Early research (Phase 1)Study completedNCT01916408
What this trial is testing

The Effects of Enzymes and Flavonoids on Inflammation and Coagulation After Marathon

Who this might be right for
InflammationDeath, Sudden, CardiacDeath+6 more
Technical University of Munich 160
Not applicableStudy completedNCT00666289
What this trial is testing

Familial Myeloproliferative Disorders

Who this might be right for
Polycythemia VeraEssential ThrombocythemiaIdiopathic Myelofibrosis
Icahn School of Medicine at Mount Sinai 17
Post-approval studies (Phase 4)Active Not RecruitingNCT05181618
What this trial is testing

Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis

Who this might be right for
Severe Hemophilia AModerate Hemophilia A
Hoffmann-La Roche 136
Next Page